{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:52:53Z","timestamp":1791305573897,"version":"4.3.1"},"reference-count":0,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":479,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>All lipoproteins are able to bind to bacterial lipopolysaccharide (LPS), thereby neutralizing its deleterious effects. However, we demonstrated, recently, that in the absence of apolipoprotein E (apoE), eight\u2010fold increased very\u2010low\u2010density lipoprotein levels were not sufficient to protect apoE\u2010deficient (apoE<jats:sup>\u2212\/\u2212<\/jats:sup>) mice against LPS. During a live Gram\u2010negative infection, mechanisms other than LPS\u2010neutralization may play a role in the pathogenesis of the disease. In the present study we further examined the role of apoE in Gram\u2010negative sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Survival, bacterial outgrowth in liver, spleen, kidneys and blood, and tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1) production were measured in apoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice and control C57BL\/6J mice, after an intravenous infection with <jats:italic>Klebsiella pneumoniae<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mice that lack apoE showed higher mortality in response to <jats:italic>K. pneumoniae<\/jats:italic> than control mice (90% vs. 23% respectively after 2\u2003weeks). ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice had 10\u2013100 times more outgrowth of the bacteria in their organs than controls. Furthermore, circulating TNF\u2010\u03b1 concentrations 90\u2003min after a challenge, were almost twice as high in the apoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice compared to controls (13.0\u2003\u00b1\u20032.9\u2003ng\u2003mL<jats:sup>\u22121<\/jats:sup> vs. 7.6\u2003\u00b1\u20033.8\u2003ng\u2003mL<jats:sup>\u22121<\/jats:sup>). When apoE<jats:sup>\u2212\/\u2212<\/jats:sup> and control mice were rendered neutropenic, the discrepancy in survival and outgrowth of <jats:italic>K. pneumoniae<\/jats:italic> disappeared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The apoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice were more susceptible than control C57BL\/6 mice to a <jats:italic>K. pneumoniae<\/jats:italic> infection. The absence of apoE may render these mice more susceptible, since this protein is of importance in the detoxification of lipopolysaccharide of Gram\u2010negative bacteria. On the other hand, the phagocytic capacity of granulocytes seems to be decreased in apoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice, resulting in increased outgrowth and mortality.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2362.2000.00715.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:49:32Z","timestamp":1047397772000},"page":"818-822","source":"Crossref","is-referenced-by-count":64,"title":["Apolipoprotein E\u2010deficient mice have an impaired immune response to <i>Klebsiella pneumoniae<\/i>"],"prefix":"10.1111","volume":"30","author":[{"family":"De Bont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Demacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Van Der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Stalenhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2000.00715.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2000.00715.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.2000.00715.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T16:22:01Z","timestamp":1698596521000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.2000.00715.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1046\/j.1365-2362.2000.00715.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.2000.00715.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}